Select Publications

Book Chapters

Baysari M; Chan J; Carland J; Stocker S; Moran M; Day R, 2018, 'Usability of Reports Generated by a Computerised Dose Prediction Software', in Connecting the System to Enhance the Practitioner and Consumer Experience in Healthcare, IOS Press, Netherlands, pp. 27 - 32, http://dx.doi.org/10.3233/978-1-61499-890-7-27

Day R; pile KD; graham GG; katelaris C, 2016, 'Antimalarial Drugs', in Compendium of Inflammatory Diseases, Springer Basel, Basel, pp. 97 - 101, http://dx.doi.org/10.1007/978-3-7643-8550-7

Day R; graham GG, 2016, 'Coxibs', in Compendium of Inflammatory Diseases, Springer Basel, pp. 1 - 7, http://dx.doi.org/10.1007/978-3-0348-0620-6_22-1

Graham GG; Roberts MS; Day RO; Rainsford KD, 2016, 'Pharmacokinetics and metabolism of the salicylates', in Aspirin and Related Drugs, pp. 97 - 155

Day RO; Graham GG, 2013, 'Non-steroidal anti-inflammatory drugs', in Encyclopedia of Inflammatory Diseases, edn. 6, Springer-Verlag, Berlin Heidelberg, http://www.springerreference.com/

Day RO; Graham GG; Williams KM, 2013, 'Propionic acid derivative drugs (Profens)', in Encyclopedia of Inflammatory Diseases, Springer-Verlag, Berlin Heidelberg, http://www.springerreference.com/

Graham GG; Day RO, 2013, 'Salicylates', in Encyclopedia of Inflammatory Diseases, Springer-Verlag, Berlin Heidelberg, http://www.springerreference.com/

Day RO; Williams KM; Graham GG, 2013, 'Urate-lowering therapy: Uricosurics', in Dalbeth N; Peresa-Ruiz F; Schlesinger N (ed.), Gout, Future Medicine Ltd, pp. 174 - 188, http://dx.doi.org/10.2217/ebo.13.104

Pile K; Graham GG; Mahler SM; Day RO, 2011, 'Disease modifying antirheumatic drugs', in Nijkamp FP; Parnham MJ (ed.), Principles of Immunopharmacology, edn. 3, Birkhauser Verlag (Springer), Basel, Switzerland, pp. 585 - 619, http://books.google.com.au/books?id=X0deXiGtcCAC&printsec=frontcover#v=onepage&q&f=false

Baysari MT; Westbrook J; Day RO, 2011, 'Medication decision-making on hospital ward-rounds', in Moen A; Andersen SK; Aarts J; Hurlen P (ed.), Studies in Health Technology and Informatics, IOS Press, Amsterdam, pp. 935 - 939, http://dx.doi.org/10.3233/978-1-60750-806-9-935

Bachmeier CJ; Brooks PM; Day RO; Graham GG; Littlejohn GO; Morand E; Pile K; Williams KM, 2005, 'Disease-modifying anti-rheumatic drugs (DMARD)', in Nijkamp FJ; Parnham MJ (ed.), Principles of Immunopharmacology (2nd Ed), edn. 2nd, Birkhauser Verlag, Basel, pp. 511 - 544

Day RO, 2003, 'Therapy of osteoarthritis', in Scott D; Cope A (ed.), The Year in Rheumatic Disorders 2003, edn. First, Clinical Publishibg Services Ltd, Oxford, United Kingdom, pp. 23 - 34

Day RO; Quinn DE; Williams KK; Handel ML; Brooks PM, 2000, 'Connective tissue and bone disorders', in Melmon and Morrelli`s clinical pharmacology: basic principles in therapeutics, edn. Original, McGrath Hill, New York, pp. 645 - 702

Day RO, 2000, 'Rheumatic Disorders', in Melmon and Morrelli`s clinical pharmacology: basic principles in therapeutics, edn. Original, McGrath Hill, New York, pp. 645 - 702

Day RO; Quinn DI; March LM; Graham GG; Williams KM, 2000, 'Rheumatoid arthritis. New Frontiers in pathogenesis and treatment', in NSAIDs and analgesics, edn. Original, Oxford University Press, Oxford, England, pp. 307 - 328

Brady S; Day RO; Graham GG, 1999, 'Are Intra-Articular steroids as effective?', in Challenges in Rheumatoid Arthritis, edn. Original, Blackwell Science, Oxford, UK, pp. 174 - 189

Bachmeier CJ; Handel ML; Conaghan PG; Williams KM; Graham GG; Brooks PM; Day RO, 1999, 'Disease-modifying antirheumatic drugs', in Nijkamp FP; Parnham MJ (ed.), Principles of Immunopharmacology, edn. 3, Birkhauser Verlag (Springer), Basel, Switzerland, pp. 379 - 403

Graham GG; Milligan MK; Day RO; Williams KM; Ziegler JB, 1998, 'Therapeutic considerations from pharmacokinetics and metabolism: ibuprofen and paracetamol', in Rainsford KD; Powanda MC (ed.), Safety and Efficacy of non-prescription (OTC) analgesics and NSAIDs, Kluwer Academic Publishers, Dordrecht, pp. 77 - 92, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000081416000006&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Brooks PM; Savdie E; Day RO, 1998, 'Antirheumatic drugs and renal disease', in Rheumatology (2nd Ed), edn. Original, Gower, London, pp. 28 - 29

Brooks PM; Day RO, 1998, 'Arthritis', in Drug Therapy in old age, edn. Original, Wiley & Sons, Chichester UK, pp. 387 - 400

Bachmeier CJ; Handel ML; Conaghan PG; Williams KM; Graham GG; Brooks PM; Day RO, 1998, 'Disease Modifying antirheumatic drugs', in Textbook of Immunopharmacology, edn. 3, Burkhauser, Basel, Switzerland, pp. 183 - 190, http://dx.doi.org/10.1097/00002281-199705000-00003

Day RO, 1998, 'Formulary and Guide to Prescribing (second edition)', in Formulary Guide to Prescribing (2nd Ed), edn. Original, St. Vincent's Hospital, Sydney, Australia, pp. 1 - 445

Yeomans N; Brooks PM; Day RO, 1998, 'Non steroidal anti-inflammatory drugs and peptic ulceration', in Rheumatology (2nd Ed), edn. Original, Gower, London, pp. 27 - 28

Day RO, 1998, 'SARDS', in Rheumatology (2nd Ed), edn. Original, Gower, London, pp. 8.1 - 8.10

Quinn DE; Day RO, 1997, 'Guide to Clinically More Important Drug Interactions.', in Drug Safety, edn. Original, Adis International Limited, Auckland, New Zealand, pp. 1665 - 1700

Day RO, 1997, 'Sulfasalazine.', in In: `The Textbook of Rheumatology`, Edition 5., edn. Original, pp. 741 - 746

Graham GG; Milligan MK; Day RO; Williams KM; Zeig , 1997, 'Therapeutic considerations from pharmacokinetics and metabolism: ibuprofen and paracetamol', in In: `Safety and efficacy of non-prescription (OTC) analgesics, edn. Original, Kluwer Academic Publishers, Great Britain, pp. 77 - 92

Journal articles

Carland JE; Stacy AE; Schaffer AL; Day RO; Brett J; Reuter SE; Stocker SL, 2023, 'Blood, dose recommendation reports and phone calls - Experiences of a Therapeutic Drug Monitoring Advisory Service for vancomycin.', Br J Clin Pharmacol, http://dx.doi.org/10.1111/bcp.15668

Spragg JCJ; Michael TJF; Aslani P; Coleshill MJ; Chan JS; Day RO; Stocker SL, 2023, 'Optimizing adherence to allopurinol for gout: patients' perspectives.', Br J Clin Pharmacol, http://dx.doi.org/10.1111/bcp.15657

Jones CMP; Lin CWC; Day RO; Koes BW; Latimer J; Maher CG; McLachlan A; Billot L, 2022, 'OPAL: a randomised, placebo-controlled trial of opioid analgesia for the reduction of pain severity in people with acute spinal pain—a statistical analysis plan', Trials, vol. 23, http://dx.doi.org/10.1186/s13063-022-06028-y

Kamel B; Abuhelwa AY; Foster D; Duong JK; Graham GG; Williams KM; Pile KD; Day RO, 2022, 'Population pharmacokinetic modelling of febuxostat in healthy subjects and people with gout', British Journal of Clinical Pharmacology, vol. 88, pp. 5359 - 5368, http://dx.doi.org/10.1111/bcp.15462

Coleshill MJ; Day RO; Tam K; Kouhkamari M; Caillet V; Aung E; Kannangara DRW; Cronin P; Rodgers A; Stocker SL, 2022, 'Persistence with urate-lowering therapy in Australia: A longitudinal analysis of allopurinol prescriptions', British Journal of Clinical Pharmacology, vol. 88, pp. 4894 - 4901, http://dx.doi.org/10.1111/bcp.15435

Tiwary M; Milder TY; Stocker SL; Day RO; Greenfield JR, 2022, 'Sodium-glucose co-transporter 2 inhibitor therapy: use in chronic kidney disease and adjunctive sodium restriction', Internal Medicine Journal, vol. 52, pp. 1666 - 1676, http://dx.doi.org/10.1111/imj.15727

Wise S; Coleshill MJ; Taylor N; Le M; Debono D; Day RO; Melocco T; Baysari MT; Laba TL; Carland JE, 2022, 'Australian hospital outpatient pharmacies: service adaptations during the 2020 national coronavirus disease 2019 lockdown', Journal of Pharmacy Practice and Research, vol. 52, pp. 326 - 328, http://dx.doi.org/10.1002/jppr.1810

Abdel Shaheed C; Beardsley J; Day RO; McLachlan AJ, 2022, 'Immunomodulatory effects of pharmaceutical opioids and antipyretic analgesics: Mechanisms and relevance to infection', British Journal of Clinical Pharmacology, vol. 88, pp. 3114 - 3131, http://dx.doi.org/10.1111/bcp.15281

Pearce A; Terrill B; Alffenaar JW; Patanwala AE; Kummerfeld S; Day R; Young MA; Stocker SL, 2022, 'Pharmacogenomic testing: perception of clinical utility, enablers and barriers to adoption in Australian hospitals', Internal Medicine Journal, vol. 52, pp. 1135 - 1143, http://dx.doi.org/10.1111/imj.15719

Rizzo RRN; Ferraro MC; Wewege MA; Cashin AG; Leake HB; O'Hagan ET; Jones MD; Gustin SM; McLachlan AJ; Day R; McAuley JH, 2022, 'Targeting neurotrophic factors for low back pain and sciatica: A systematic review and meta-analysis', Rheumatology (United Kingdom), vol. 61, pp. 2243 - 2254, http://dx.doi.org/10.1093/rheumatology/keab785

Abdel Shaheed C; Awal W; Zhang G; Gilbert SE; Gallacher D; McLachlan A; Day RO; Ferreira GE; Jones CMP; Ahedi H; Tamrakar M; Blyth FM; Stanaway F; Maher CG, 2022, 'Efficacy, safety, and dose-dependence of the analgesic effects of opioid therapy for people with osteoarthritis: systematic review and meta-analysis', Medical Journal of Australia, vol. 216, pp. 305 - 311, http://dx.doi.org/10.5694/mja2.51392

Sandaradura I; Alffenaar JW; Cotta MO; Daveson K; Day RO; Van Hal S; Lau C; Marriott DJE; Penm J; Roberts JA; Tabah A; Williams P; Imani S, 2022, 'Emerging therapeutic drug monitoring of anti-infective agents in Australian hospitals: Availability, performance and barriers to implementation', British Journal of Clinical Pharmacology, vol. 88, pp. 669 - 679, http://dx.doi.org/10.1111/bcp.14995

Kirubakaran R; Hennig S; Maslen B; Day RO; Carland JE; Stocker SL, 2022, 'Evaluation of published population pharmacokinetic models to inform tacrolimus dosing in adult heart transplant recipients', British Journal of Clinical Pharmacology, vol. 88, pp. 1751 - 1772, http://dx.doi.org/10.1111/bcp.15091

Kirubakaran R; Uster DW; Hennig S; Carland JE; Day RO; Wicha SG; Stocker SL, 2022, 'Adaptation of a population pharmacokinetic model to inform tacrolimus therapy in heart transplant recipients', British Journal of Clinical Pharmacology, http://dx.doi.org/10.1111/bcp.15566

Li L; Baker J; Rathnayake K; Kotwal S; Westbrook JI; Day R; Endre Z, 2022, 'Medication use and hospital-acquired acute kidney injury: an electronic health record-based study', Internal Medicine Journal, http://dx.doi.org/10.1111/imj.15938

Simic M; Harmer AR; Agaliotis M; Nairn L; Bridgett L; March L; Votrubec M; Edmonds J; Woodward M; Day R; Fransen M, 2021, 'Clinical risk factors associated with radiographic osteoarthritis progression among people with knee pain: a longitudinal study', Arthritis Research and Therapy, vol. 23, http://dx.doi.org/10.1186/s13075-021-02540-9

Ferdiana A; Liverani M; Khan M; Wulandari LPL; Mashuri YA; Batura N; Wibawa T; Yeung S; Day R; Jan S; Wiseman V; Probandari A, 2021, 'Community pharmacies, drug stores, and antibiotic dispensing in Indonesia: a qualitative study', BMC Public Health, vol. 21, http://dx.doi.org/10.1186/s12889-021-11885-4

Ferraro MC; Bagg MK; Wewege MA; Cashin AG; Leake HB; Rizzo RRN; Jones MD; Gustin SM; Day R; Loo CK; McAuley JH, 2021, 'Efficacy, acceptability, and safety of antidepressants for low back pain: a systematic review and meta-analysis', Systematic Reviews, vol. 10, pp. 62, http://dx.doi.org/10.1186/s13643-021-01599-4

Chan DKY; Day R, 2021, 'Precision medicine and clinical relevance in older people', Aging Medicine, vol. 4, pp. 292 - 293, http://dx.doi.org/10.1002/agm2.12178

Kirubakaran R; Stocker SL; Carlos L; Day RO; Carland JE, 2021, 'Tacrolimus Therapy in Adult Heart Transplant Recipients: Evaluation of a Bayesian Forecasting Software', Therapeutic drug monitoring, vol. 43, pp. 736 - 746, http://dx.doi.org/10.1097/FTD.0000000000000909

Roydhouse SA; Carland JE; Debono DS; Baysari MT; Reuter SE; Staciwa AJ; Sandhu APK; Day RO; Stocker SL, 2021, 'Accuracy of documented administration times for intravenous antimicrobial drugs and impact on dosing decisions', British Journal of Clinical Pharmacology, vol. 87, pp. 4273 - 4282, http://dx.doi.org/10.1111/bcp.14844

Carland JE; Stocker SL; Baysari MT; Li C; Själin J; Moran MA; Tang S; Sandaradura I; Elhage T; Gilbey T; Williams KM; Marriott DJE; Day RO, 2021, 'Are vancomycin dosing guidelines followed? A mixed methods study of vancomycin prescribing practices', British Journal of Clinical Pharmacology, vol. 87, pp. 4221 - 4229, http://dx.doi.org/10.1111/bcp.14834

Counsell AB; Nguyen AD; Baysari MT; Kannangara DRW; Gamboa S; Day RO, 2021, 'Expanding the role of Australian community dietitians in gout management', International Journal of Rheumatic Diseases, vol. 24, pp. 1402 - 1408, http://dx.doi.org/10.1111/1756-185X.14224


Back to profile page